北美基因分型市场预测至 2031 年 – 区域分析 – 按产品类型(仪器、试剂和试剂盒、生物信息学和基因分型服务)、技术(微阵列、毛细管电泳、测序、聚合酶链反应 (PCR)、基质辅助激光解吸/MALDI-TOF 和其他技术)、应用(药物基因组学、诊断和个性化医疗、动物遗传学、农业生物技术和其他应用)和最终用户(制药和生物制药公司、诊断和研究实验室、学术机构和其他最终用户)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031


No. of Pages: 147    |    Report Code: BMIRE00025971    |    Category: Life Sciences

North America Genotyping Market
2023 年北美基因分型市场价值为 120.4457 亿美元,预计到 2031 年将达到 629.0063 亿美元;预计 2023 年至 2031 年的复合年增长率为 23.0%。

在遗传和罕见疾病诊断中的应用推动了北美基因分型市场的发展

根据世界卫生组织 (WHO) 的数据,2050 年可能会出现约 3500 万例新的癌症病例,比 2022 年的 2000 万例增加 77%。2022 年,阿尔茨海默病协会表示,美国患有阿尔茨海默病的人数正在迅速增加。这种疾病影响着超过 600 万各个年龄段的美国人。根据该协会的估计,截至 2022 年,650 万 65 岁以上的美国人患有阿尔茨海默病,其中 73% 的人年龄在 75 岁或以上。根据《健康监测杂志》发表的一项研究,全世界有多达 3 亿人患有罕见病。虽然个别疾病很少见,但它们共同对全球医疗保健系统构成了重大挑战。

由于癌症、阿尔茨海默病和罕见病在临床上难以识别,因此基因分型成为人群诊断检测的支柱。从基因分型获得的 DNA 序列可以与样本或参考序列进行比较以确定变异。基因分型还用于检测单核苷酸多态性 (SNP),即人群中遗传补体的微小变异。人类基因组有近 6.6 亿个 SNP,这使它们成为最普遍的遗传变异。此外,通过比较健康和患病人群的多态性,全基因组关联研究 (GWAS) 可以揭示常见疾病与 SNP 之间的联系。GWAS 可以通过寻找可能的原因来解开潜在疾病状态的分子机制。SNP 甚至存在于单细胞生物中,例如细菌。SNP 基因分型可以区分微生物分离物,甚至可以用于识别抗生素耐药菌株。基于 SNP 的菌株检测对每种药物和临床分析都有重大影响,并且还已用于传染病流行病学。

北美基因分型市场概览

北美基因分型市场分为美国、加拿大和墨西哥。越来越多地采用技术先进的产品和解决方案,以及激增的研发活动是该地区基因分型市场受益的因素。此外,政府主导的项目(例如“我们所有人的研究计划”)、各个基因组学社区的举措以及人们对基因分型服务的日益认识是推动北美市场扩张的主要驱动力。

北美基因分型市场收入和预测到 2031 年(百万美元)

北美基因分型市场细分

北美基因分型市场分为产品、技术、应用、最终用户和国家。

基于产品,北美基因分型市场细分为仪器、试剂和试剂盒、生物信息学和基因分型服务。试剂和试剂盒部分在 2023 年占据了最大的市场份额。

按技术,北美基因分型市场分为微阵列、毛细管电泳、测序、聚合酶链反应 (PCR)、基质辅助激光解吸/MALDI-TOF 和其他技术。聚合酶链反应 (PCR) 细分市场在 2023 年占据最大市场份额。

根据应用,北美基因分型市场细分为药物基因组学、诊断和个性化医疗、动物遗传学、农业生物技术和其他应用。诊断和个性化医疗细分市场在 2023 年占据最大市场份额。

就最终用户而言,北美基因分型市场分为制药和生物制药公司、诊断和研究实验室、学术机构和其他最终用户。制药和生物制药公司细分市场在 2023 年占据最大市场份额。

根据分销渠道,北美基因分型市场细分为药店、零售店和在线。药店细分市场在 2023 年占据最大市场份额。

按国家/地区划分,北美基因分型市场细分为美国、加拿大和墨西哥。 2023 年,美国占据了北美基因分型市场的主导份额。

Hoffmann-La Roche Ltd、QIAGEN NV、Merck KGaA、Thermo Fisher Scientific Inc、BioTek Instruments, Inc、TRIMGEN CORPORATION、Illumina Inc、Danaher Corp、Bio-Rad Laboratories Inc、GE HealthCare Technologies Inc、Standard BioTools Inc、Laboratory Corp of America Holdings、Beckman Coulter Inc、BGI、Takara Bio Inc 和 DiaSorin SpA 是北美基因分型市场的一些领先公司。

North America Genotyping Strategic Insights

Strategic insights for North America Genotyping involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-genotyping-market-strategic-framework.webp
Get more information on this report

North America Genotyping Report Scope

Report Attribute Details
Market size in 2023 US$ 12,044.57 Million
Market Size by 2031 US$ 62,900.63 Million
Global CAGR (2023 - 2031) 23.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品类型
  • 仪器
  • 试剂和试剂盒
  • 生物信息学
  • 基因分型服务
By 技术
  • 微阵列
  • 毛细管电泳
  • 测序
  • 聚合酶链式反应
  • 基质辅助激光解吸/MALDI-TOF
  • 其他技术
By 应用
  • 药物基因组学
  • 诊断和个性化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用
By 最终用户
  • 制药和生物制药公司
  • 诊断和研究实验室
  • 学术机构
  • 其他最终用户
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • TRIMGEN CORPORATION.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Get more information on this report

    North America Genotyping Regional Insights

    The regional scope of North America Genotyping refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-genotyping-market-geography.webp
    Get more information on this report

    The List of Companies - North America Genotyping Market

    • Hoffmann-La Roche Ltd.
    • QIAGEN NV.
    • Merck KGaA.
    • Thermo Fisher Scientific Inc.
    • BioTek Instruments, Inc.
    • TRIMGEN CORPORATION.
    • Illumina Inc.
    • Danaher Corp.
    • Bio-Rad Laboratories Inc.
    • GE HealthCare Technologies Inc.
    • Standard BioTools Inc.
    • Laboratory Corp of America Holdings.
    • Beckman Coulter Inc.
    • BGI.
    • Takara Bio Inc.
    • DiaSorin SpA.
    Frequently Asked Questions
    How big is the North America Genotyping Market?

    The North America Genotyping Market is valued at US$ 12,044.57 Million in 2023, it is projected to reach US$ 62,900.63 Million by 2031.

    What is the CAGR for North America Genotyping Market by (2023 - 2031)?

    As per our report North America Genotyping Market, the market size is valued at US$ 12,044.57 Million in 2023, projecting it to reach US$ 62,900.63 Million by 2031. This translates to a CAGR of approximately 23.0% during the forecast period.

    What segments are covered in this report?

    The North America Genotyping Market report typically cover these key segments-

  • 产品类型 (仪器, 试剂和试剂盒, 生物信息学, 基因分型服务)
  • 技术 (微阵列, 毛细管电泳, 测序, 聚合酶链式反应, 基质辅助激光解吸/MALDI-TOF, 其他技术)
  • 应用 (药物基因组学, 诊断和个性化医疗, 动物遗传学, 农业生物技术, 其他应用)
  • What is the historic period, base year, and forecast period taken for North America Genotyping Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Genotyping Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in North America Genotyping Market?

    The North America Genotyping Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • TRIMGEN CORPORATION.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Standard BioTools Inc.
  • Laboratory Corp of America Holdings.
  • Beckman Coulter Inc.
  • BGI.
  • Takara Bio Inc.
  • DiaSorin SpA.
  • Who should buy this report?

    The North America Genotyping Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Genotyping Market value chain can benefit from the information contained in a comprehensive market report.